These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28603047)

  • 1. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
    Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H
    Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension.
    Yamamura A; Yagi S; Ohara N; Tsukamoto K
    Eur J Pharmacol; 2016 Aug; 784():15-21. PubMed ID: 27164419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
    Yamamura A; Ohara N; Tsukamoto K
    PLoS One; 2015; 10(9):e0138384. PubMed ID: 26375676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin-induced Ca
    Song S; Ayon RJ; Yamamura A; Yamamura H; Dash S; Babicheva A; Tang H; Sun X; Cordery AG; Khalpey Z; Black SM; Desai AA; Rischard F; McDermott KM; Garcia JG; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L309-L325. PubMed ID: 27979859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Nakamura K; Akagi S; Ogawa A; Kusano KF; Matsubara H; Miura D; Fuke S; Nishii N; Nagase S; Kohno K; Morita H; Oto T; Yamanaka R; Otsuka F; Miura A; Yutani C; Ohe T; Ito H
    Int J Cardiol; 2012 Aug; 159(2):100-6. PubMed ID: 21376411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated ClC3 Channels/Transporters Elicit Swelling-Activated Cl
    Amano T; Yamamura A; Fujiwara M; Hirai S; Kondo R; Suzuki Y; Yamamura H
    Biol Pharm Bull; 2022 Nov; 45(11):1684-1691. PubMed ID: 35989293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.
    Fantozzi I; Huang W; Zhang J; Zhang S; Platoshyn O; Remillard CV; Thistlethwaite PA; Yuan JX
    Exp Lung Res; 2005 Oct; 31(8):783-806. PubMed ID: 16368652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-type Ca
    Sankhe S; Manousakidi S; Antigny F; Arthur Ataam J; Bentebbal S; Ruchon Y; Lecerf F; Sabourin J; Price L; Fadel E; Dorfmüller P; Eddahibi S; Humbert M; Perros F; Capuano V
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1631-1641. PubMed ID: 28655554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Akagi S; Nakamura K; Matsubara H; Kusano KF; Kataoka N; Oto T; Miyaji K; Miura A; Ogawa A; Yoshida M; Ueda-Ishibashi H; Yutani C; Ito H
    Int J Cardiol; 2013 May; 165(3):499-505. PubMed ID: 21955608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Yamamura A; Nayeem MJ; Sato M
    Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.
    Kawade A; Yamamura A; Kondo R; Suzuki Y; Yamamura H
    J Pharmacol Sci; 2023 Feb; 151(2):119-127. PubMed ID: 36707177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.
    Barnes JW; Tian L; Heresi GA; Farver CF; Asosingh K; Comhair SA; Aulak KS; Dweik RA
    Circulation; 2015 Apr; 131(14):1260-8. PubMed ID: 25663381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular Mechanism of Dihydropyridine Ca
    Yamamura A
    Yakugaku Zasshi; 2016; 136(10):1373-1377. PubMed ID: 27725386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.
    Perros F; Sentenac P; Boulate D; Manaud G; Kotsimbos T; Lecerf F; Lamrani L; Fadel E; Mercier O; Londono-Vallejo A; Humbert M; Eddahibi S
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells.
    Miyaki R; Yamamura A; Kawade A; Fujiwara M; Kondo R; Suzuki Y; Yamamura H
    Biochem Biophys Res Commun; 2022 Jun; 607():44-48. PubMed ID: 35366542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
    Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
    PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Ikeda T; Nakamura K; Akagi S; Kusano KF; Matsubara H; Fujio H; Ogawa A; Miura A; Miura D; Oto T; Yamanaka R; Otsuka F; Date H; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):39-48. PubMed ID: 19786891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension.
    Papp R; Nagaraj C; Zabini D; Nagy BM; Lengyel M; Skofic Maurer D; Sharma N; Egemnazarov B; Kovacs G; Kwapiszewska G; Marsh LM; Hrzenjak A; Höfler G; Didiasova M; Wygrecka M; Sievers LK; Szucs P; Enyedi P; Ghanim B; Klepetko W; Olschewski H; Olschewski A
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31023847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
    Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes.
    Kunichika N; Landsberg JW; Yu Y; Kunichika H; Thistlethwaite PA; Rubin LJ; Yuan JX
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1101-7. PubMed ID: 15317671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.